| [1] |
Haugen BR, Alexander EK, Bible KC, et al.
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. ThyroidThyroid, 2016, 26(1): 1-133.
doi: 10.1089/thy.2015.0020 |
| [2] |
汤敏敏, 刘建中, 武志芳, 等. 分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估[J]. 中华放射医学与防护杂志, 2015, 35(4): 299−302. DOI: 10.3760/cma.j.issn.0254−5098.2015.04.016. Tang MM, Liu JZ, Wu ZF, et al. Estimation of residual activity in patients with differentiated thyroid cancer after administration of 131I for therapy[J]. Chin J Radiol Med Prot, 2015, 35(4): 299−302. DOI: 10.3760/cma.j.issn.0254−5098.2015.04.016. |
| [3] |
任庆余, 王琳杰, 赵进沛.
碘-131治疗分化型甲状腺癌外照射辐射剂量研究[J]. 中国职业医学中国职业医学, 2017, 44(5): 625-628.
doi: 10.11763/j.issn.2095-2619.2017.05.021 Ren QY, Wang LJ, Zhao JP. Study on external exposure dose level of I-131 therapy for differentiated thyroid carcinoma[J]. China Occup MedChina Occup Med, 2017, 44(5): 625-628. doi: 10.11763/j.issn.2095-2619.2017.05.021 |
| [4] |
中华人民共和国国家卫生和计划生育委员会. WS 533−2017 临床核医学患者防护要求 [S]. 北京: 中国标准出版社, 2017: 36−38. National Health and Family Planning Commission of the People's Republic of China. WS 533−2017 Requirements for patient radiation protection in clinical nuclear medicine[S]. Beijing: Standards Press of China, 2017: 36−38. |
| [5] |
中华人民共和国卫生部. GBZ 133−2009 医用放射性废物的卫生防护管理[S]. 北京: 人民卫生出版社, 2010: 1−3. Ministry of Health of the People's Republic of China. GBZ 133−2009 Radiological protection management for medical radioactive waste[S]. Beijing: People's Medical Publishing House, 2010: 1−3. |
| [6] |
Willegaignon J, Sapienza M, Ono C, et al.
Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure[J]. Clin Nucl MedClin Nucl Med, 2011, 36(6): 440-445.
doi: 10.1097/RLU.0b013e3182184fa0 |
| [7] |
郭海珍, 姚兰, 万贤琴.
基于网络信息平台在分化型甲状腺癌131I治疗患者延续护理中的应用[J]. 护理与康复护理与康复, 2019, 18(1): 76-78.
doi: 10.3969/j.issn.1671-9875.2019.01.025 Guo HZ, Yao L, Wan XQ. Application of network information platform based transitional care for patients with differentiated thyroid carcinoma undergoing 131I treatment[J]. J Nurs RehabilJ Nurs Rehabil, 2019, 18(1): 76-78. doi: 10.3969/j.issn.1671-9875.2019.01.025 |
| [8] |
廖昂, 丁炜, 黄永祥, 等.
分化型甲状腺癌131碘治疗期间辐射安全教育及管理[J]. 中国卫生产业中国卫生产业, 2018, 15(3): 48-49.
doi: 10.16659/j.cnki.1672-5654.2018.03.048 Liao A, Ding W, Huang YX, et al. Radiation Safety Education and Management During the Treatment Period of Differentiated Thyroid Carcinoma 131 Iodine[J]. China Health IndChina Health Ind, 2018, 15(3): 48-49. doi: 10.16659/j.cnki.1672-5654.2018.03.048 |